Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ninian Lang MB ChB, PhD

Ninian N. Lang MB ChB, PhD

Professor of Cardiology and Cardio-Oncology, School of Cardiovascular and Metabolic Health, University of Glasgow, Scotland, United Kingdom

Ninian Lang is Professor of Cardiology and Cardio-Oncology at the University of Glasgow. He serves as an Honorary Consultant Cardiologist at the Queen Elizabeth University Hospital and the Beatson West of Scotland Cancer Centre. His clinical and academic work focuses on cardio-oncology and heart failure. He is a Fellow of the Royal College of Physicians (Edinburgh) and of the European Society of Cardiology. He is an Associate Editor of the JACC:CardioOncology.


Ninian Lang was a co-author of the Cardiac CARE trial which was funded by a Medical Research Council and NIHR partnership, and the British Heart Foundation (15/48/20). He is supported by a British Heart Foundation Centre of Research excellence award (RE/18/6/34217). He has received personal fees from Akero, Roche, Pfizer, Jazz Pharma, CV6 Therapeutics and Novartis and research grant support from Roche Diagnostics, Boehringer Ingelheim and Astra Zeneca all administered by his employer (The University of Glasgow), all outside the submitted work.